Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A single arm study to assess the efficacy and safety of bevacizumab in combination with irinotecan and infusional 5-fluorouracil/folic acid regimens as first line treatment for patients with metastatic colorectal cancer.
Bevacizumab
MO18458
metastatic colorectal cancer
Phase 4
 
April 2015

Powered by ideaPoint, Inc.